HeartSciences Inc Warrant
HSCSW
3 hedge funds and large institutions have $27.9K invested in HeartSciences Inc Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
1.06% less ownership
Funds ownership: 27.74% → 26.68% (-1.1%)
59% less capital invested
Capital invested by funds: $67.5K → $27.9K (-$39.6K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$1.42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CS
1
Clear Street
New York
| $19K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $8.82K | -$1.42K | -18,539 | -9% |
|
3
UBS Group
Zurich,
Switzerland
| $23 | – | – | – |
|
HSCSW Hedge Fund Activity: Q4 2025 in Review
3 of the 8,229 institutional investors tracked by Wall St. Rank reported a position in HeartSciences Inc Warrant (HSCSW) for Q4 2025, worth a combined $27.9K — down 59% from $67.5K a quarter earlier.
Fund positioning in HSCSW was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $1.42K.
- 3 institutional investors held HeartSciences Inc Warrant (HSCSW) as of Q4 2025, unchanged from Q3 2025.
- Funds reported $27.9K of HeartSciences Inc Warrant stock for Q4 2025, down 59% quarter-over-quarter.
- 0 funds opened new HeartSciences Inc Warrant positions in Q4 2025 and 0 closed out.
- The largest HeartSciences Inc Warrant seller in Q4 2025 was Citadel Advisors, an estimated $1.42K sold.
Based on aggregated 13F filings for Q4 2025.